Presidential Office "Contract Signed for 260,000 COVID-19 Treatment Doses... Supply Expansion Planned"

"In Discussion with Pharmaceutical Companies Regarding Detailed Schedule"

Jeong Hye-jeon, spokesperson for the Presidential Office, is holding a briefing on current issues at the Presidential Office building in Yongsan, Seoul, on the 16th.
[Image source=Yonhap News]

In response to the recent surge in COVID-19 cases, the Presidential Office announced on the 16th that it is "in the process of signing a purchase contract to supply 260,000 doses of treatment drugs."

A Presidential Office official told reporters in the afternoon, "We are currently actively responding to the resurgence of COVID-19," and made the statement.

The official explained, "The Korea Disease Control and Prevention Agency has established and announced public prevention guidelines, including recommendations for wearing masks, and emergency reserve funds have been secured to meet the increased demand for treatment drugs."

He added, "Since yesterday, additional supplies of oral and injectable treatments have begun," and said, "We plan to expand the volume of imported supplies and sequentially introduce treatments urgently, and are currently negotiating detailed schedules with pharmaceutical companies."

This content was produced with the assistance of AI translation services.